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The analysis presented here lays out the ethical warrants for requiring community oversight of health research
conducted in international settings. It reviews the inadequacies with the current standards of individual informed
consent and research ethics committee review, and then, shows how a broader population-based public health
perspective raises new demands on justice involving due consideration of the rights, harms and beneﬁts to the
community as a whole. As developed here, an ethical standard that requires community oversight of health
research is justiﬁed on three principled grounds: respect for community autonomy and their right to selfdetermination; due consideration of the consequences of the research for the community as a whole; and, a more
complete understanding of human autonomy. The paper concludes with practical recommendations regarding
the composition of Community Advisory Boards to ensure that they have legitimate decision-making authority in
diverse socio-cultural contexts.
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Since the conduct of the controversial HIV–perinatal
transmission trials in the early 1990s, debates have
raged about the ethics of international health studies. In that research, pregnant women in low-income
countries were given low doses of AZT to determine whether a less expensive alternative could be developed to prevent mother-to-infant transmission of
HIV (Angell, 1997, 2000; Lurie and Wolfe, 1997).
The research raised serious questions about the potential for exploitation and the adequacy of present
protections for participants in international health
research.
In response to these controversies, a number of
bioethicists have recently issued calls to mandate com-

munity involvement in decision-making about the conduct of health research (Weijer and Emanuel, 2000;
Emanuel et al., 2004; Brody et al., 2005). One major concern raised by these analyses is whether Research Ethics
Committee (REC) reviews and individual informed consent provide sufficient ethical safeguards in all contexts
(Macklin, 2004).
Key issues left unresolved by these calls are both
the theoretical foundation that could provide the ethical justification for community monitoring and practical strategies for instituting an oversight process with
legitimized authority. To advance the development of
sound context-appropriate ethical standards, this paper
presents a principled justification for the ethical assessment of international health research protocols by community representatives. In addition, recommendations
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regarding a feasible process for achieving community
oversight are provided.
From the outset, it is important to address potential concerns that requiring an additional layer of review
might impede the timely conduct of research (Berkley,
2003; Dawson and Kass, 2005). A vastly disproportionate
share of the world’s research resources is now allocated to
studies on diseases that affect only a minority of the global
population (Global Forum, 2004). Additional review requirements on international health research would be
unjust if the net result served only to decrease access to
the benefits of research further for the majority of the
world’s population.
Our view is that, requiring another level of review is
necessary, not only to ensure ethically appropriate oversight, but also to facilitate the conduct of research by
building trust in its safety and importance. In Western industrialized nations, there has been a ‘paradigm shift’ in
public attitudes toward research participation, where the
weight of concerns has shifted from apprehension about
the risks of research participation to an appreciation of
the potential benefits (Kahn et al., 1998; McCarthy, 1998;
Powers, 1998; Buchanan and Miller, 2006a). With the
onset of the AIDS epidemic, the urgent need for effective
treatments led many people to view research participation not as a pernicious threat, but as an opportunity
to obtain the most scientifically advanced therapies possible. Since community monitoring should reduce the
threat of exploitation and thereby increase trust in its
potential benefits, specifying clear policies with respect
to the purpose and parameters of community review
should bolster confidence among potential research volunteers, and thus facilitate the conduct of research in
these settings.
The paper starts with a synopsis of concerns that have
been raised about the processes of individual informed
consent and REC review. We then examine recent issues that have emerged from the field of public health
ethics regarding the adequacy of currently accepted ethical review procedures, which were designed primarily to
monitor clinical treatment trials, and growing recognition of the need to take into account population protections. Building on that framework, we present the ethical rationale for community involvement in assessing
the ethical conduct of health research. Community oversight refers to a process of engaging community members
equitably in monitoring health intervention research to
ensure that ethical standards are upheld and the interests
of community members protected. The paper concludes
with practical recommendations regarding issues of representation to ensure fair community participation in
monitoring health research.

Problems with Individual Informed
Consent
A number of concerns have been raised about the adequacy and appropriateness of the individual informed
consent standard in the context of international health
research. These concerns include: the definition of ‘informed’ and criteria for assessing its attainment; the cultural appropriateness of individualistic decision-making
processes; concerns about the priority of individual
autonomy over other moral considerations; questions
about the utility of individual informed consent per se;
and, finally, reconsiderations of the overarching purpose
of informed consent requirements.
Faden and Beauchamp (1986) make a distinction between ‘philosophical’ and ‘policy-oriented’ definitions of
informed consent. A philosophical definition refers to a
substantial understanding of the overall research process and its implications for human interests. A policyoriented definition refers to the legal requirements enumerated in state law, such as the US Code of Federal
Regulations (45 CFR 46.116(c) and 45 CFR 46.116(d)),
which denotes eight elements (see box) that must be presented in written informed consent documents.

Eight Elements of Informed Consent
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The eight required elements of informed consent that
have been defined by US federal regulations [45 CFR
46.116(c) and 45 CFR 46.116(d)] are
1.

2.
3.

4.

5.

6.

a statement that the study involves research, an
explanation of the purposes of the research and the
expected duration of the subject’s participation,
a description of the procedures to be followed,
and identification of any procedures which are
experimental
a description of any reasonably foreseeable risks
or discomforts to the subjects
a description of any benefits to the subjects or to
others which may reasonably be expected from the
research
a disclosure of appropriate alternative procedures
or courses of treatment, if any, that might be advantageous to the subjects
a statement describing the extent, if any, to which
confidentiality of records identify the subjects will
be maintained
for research involving more than minimal risk,
an explanation as to whether any compensation
and an explanation as to whether any medical
treatments are available if injury occurs and, if
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so, what they consist of, and where further information may be obtained
7. an explanation of whom to contact for answers
to pertinent questions about the research and
research subjects’ rights, and whom to contact
in the event of a research-related injury to the
subjects
8. a statement that participation is voluntary, refusal to participate will involve no penalty or
loss of benefits to which the subjects is otherwise entitled, and the subjects may discontinue
participation at any time without penalty or loss
of benefits to which the subjects is otherwise entitled.
While some legal provisions are designed to foster the
conditions in which the substantive philosophical ideal
can be attained, there are currently no established standards or criteria for determining the degree to which individuals truly understand what their participation entails.
Critically, there is a much greater distance between the
philosophical ideal and the reality of individual comprehension in contexts where participants may lack formal
education, be illiterate, live in poverty, be malnourished
or face other stressful life conditions. Furthermore, researchers and others have noted that many languages do
not have words or equivalent concepts for basic terminology such as ‘research’ or ‘hypothesis’, let alone more technical scientific language such as ‘placebo’, ‘false positives’,
and ‘randomization’ (Ekunwe and Kessel, 1984; Bayer,
1998; Moodley, 2002; MacQueen et al., 2004; Molyneux
et al., 2004; Dawson and Kass, 2005). More broadly,
many socio-cultural conceptual frameworks regarding
the etiology of disease are incongruent with Western scientific explanations. In such contexts, while the eight
elements of informed consent can perhaps be satisfactorily explained to potential participants (thus fulfilling
the policy-oriented definition of informed consent), it is
difficult to maintain that they have a proficient understanding of the nature, goals and risks of the research,
which is fundamental to providing one’s permission for
researchers to proceed with the experiment. The common requirement that informed consent documents be
written in plain language fails to address this important
ethical problem.
Issues have also been raised about the imposition of
Western norms of individual decision-making in contexts where such practices are foreign (Moodley, 2002;
Dawson and Kass, 2005; Woodsong and Karim, 2005).
The (Western) concern that others may exert undue influence may be based on the questionable assumption
that the interests of the individual and the community
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are inherently in conflict. In different cultural contexts,
however, social relationships may be understood to be
(at least partially) constitutive of one’s identity; for example, the traditional African concept of ‘ubuntu’ has
been defined as ‘umuntu ngumuntu ngabantu’ – ‘you
are who you are because of other people’ (Biko, 1978).
In the West, Sandel (1982) has described this broader
self-understanding as a shift from thinking in terms of
‘I’ to ‘we’, where one’s sense of identity is bound up with
the realization of a common way of life, the reproduction
of valued social practices, and the sense of community
in which one takes pride. In such contexts, not only are
the interests of the individual and the community commonly perceived to be synonymous, but the notion that
persons should make decisions independently, divorced
from their social relationships, is a patent violation of
accepted social norms. The current push for requiring
individual informed consent in all contexts appears to
be based on the tacit assumption that low-income countries are traditional societies that have not yet attained a
modern, enlightened mindset, in the sense of the emancipation of the individual and valorization of individual rights (Mamdani, 1996). This trajectory is apparently presumed to be unilinear, universal and normal,
rather than historically contingent or problematic, where
the possibility of developing ethical norms along divergent lines might remain open. In light of these opposing
considerations, the proposed standards presented here
seek to achieve an appropriate balance between concerns
about the potential for individual exploitation and the
need for respecting beneficent cultural practices.
Critics have also questioned the near-absolute priority placed on the principle of respect for individual
autonomy (from which the mandate for individual informed consent derives) over other moral considerations
in the brief history of bioethics, as it developed in the US
(Weijer, 1999; Rhodes, 2005). As Levine (1986) notes, the
work of the 1978 US National Commission must be seen
in context of its time and thus can be faulted now for its
overemphasis on individual rights, to the neglect of obligations to the larger community. More strongly, Taylor
(1985) has assailed the central tenet of liberalism, which
he calls the ‘primacy of rights’, referring to the moral view
that individual rights have priority over all other moral
considerations, such as obligations to contribute to the
collective good. However, as the well-known 1905 US
Supreme Court ruling in Jacobsen v. Massachusetts made
clear, the principle of individual freedom cannot take
absolute precedence over other moral principles. On the
contrary, since the potential benefits to society and future generations are significant, other ethicists have taken
the position that citizens should be morally obligated to
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participate in research, in order to advance the common
good, distribute risk equitably, and mitigate the free-rider
problem (Caplan, 1984; Harris, 2005; Orentlicher, 2005;
Rhodes, 2005).
Moreover, Truog and his colleagues (Truog,
Robinson, and Randolph, 1999) have questioned the
‘blind insistence’ on obtaining individual informed consent. As they state, ‘There is little evidence to support
the claim that informed consent, as currently practiced,
provides protection against the exploitation of patients
in research. Studies have shown that patients rarely have
an adequate understanding of consent forms and often do not understand the meaning or implications of
randomization.’ In its stead, they propose the use of a
‘reasonable person standard’, which could be achieved
by ‘the involvement of the community through the representation of people without medical backgrounds’ on
ethical review boards.
Finally, while great emphasis has been placed on the
need for demonstrating respect for individual autonomy,
another key purpose of informed consent has centered
on reducing inequalities of power and knowledge (President’s Commission, 1982). As described below, when
novel interventions hold the potential for affecting the
community as a whole, there is a critical need for putting
processes in place that reduce inequalities of power between research institutions and communities targeted as
potential pools for participant recruitment and eventual
dissemination. Current interest in USA in CommunityBased Participatory Research (CBPR) appears to be directly related to reducing power differentials and mitigating these ethical concerns (Wallerstein et al., 2005;
Buchanan et al., 2007). In many types of research, it is
the community as a whole that both bears the risks and
stands to gain the potential benefits of newly developed
interventions. New policies are thus imperative for redressing power imbalances and giving due consideration
to the community’s right to self-determination.

Problems with Research Ethics
Committee Review
A number of concerns have also been raised about the
adequacy of the research ethics review process, including
the composition, training, scope of authority, accountability and allegiance of review boards (Emanuel et al.,
2004). The following analysis focuses primarily on the US
system of Institutional Review Boards (IRBs), and thus
is limited to USA and other countries that have adopted
similar systems of research ethics review.
In a policy formulation that has since been called into
question, the US Congress passed regulations that cre-

ated a decentralized system of ethical review boards and
that enumerated only minimal requirements regarding
the composition of local IRBs. According to these regulations, IRBs must have at least five members ‘with varying
backgrounds to promote. . . sensitivity to such issues as
community attitudes’, ‘at least one member whose primary concerns are in non-scientific areas’, and ‘at least
one member who is not otherwise affiliated with the institution’ (US 45 CFR 46.116). In practice, this has generally
meant that institutions appoint one outside community
member to sit on a board with 10–12 other members
recruited from the ranks of experienced researchers employed by the university or research organization. As a
result, Marshall (2007, p. 17) notes that ‘most are dominated by scientists who are responsible for reviewing the
research protocols of colleagues and friends.’ US regulations do not provide any further guidance with respect
to how members should be selected.
Until quite recently, there were no requirements in
the US regarding the training or qualifications of IRB
members. In the wake of widespread public outcry over
the deaths of two research participants several years ago,
however, the US Office of Human Research Protections
instituted regulations that now require all researchers to
gain certification in research ethics; this training is generally provided by new, on-line certificate programs, which
take about 1 hour to complete. Otherwise, IRB membership is open to people with no specific knowledge,
training or experience in conducting ethical reviews.
Regarding the scope of their authority, one major concern is that IRBs in USA derive their regulatory power
from the conditions attached to federal funding; hence,
privately funded research does not fall under the purview
of IRB review but fall only under FDA inspection as it
pertains to applications for licenses to sell new drugs or
devices (Berg et al., 2001). Currently in USA, the volume and investment of health research conducted by the
pharmaceutical industry exceeds that of publicly funded
research (Bodenheimer, 2000; Rettig, 2000). While many
private corporations have voluntarily adopted the federal code of ethics regulating health research, they are
not mandated by law. In a recent report, Levinson (2007)
found that FDA regulators do not know how many clinical trials are being conducted, audit less than 1% of the
testing sites, and have only 200 inspectors to police an
estimated 350,000 testing sites. Oversight of drug trials
funded by private pharmaceutical companies in international settings is even less well monitored.
Critics have also pointed out that IRBs are accountable to no one, except the courts in instances when the
institution is sued by participant(s) to redress allegations of harm (Berg et al., 2001). Presently, if researchers,
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participants, community members, or other third parties
disagree with the decision to approve or not to approve
the research by the IRB, or with any stipulations that
are attached or not attached for modifying the protocol,
there are no provisions or standing body for appeal where
they can plead their case and seek remediation.
Finally, largely as a result of the cumulative impact of
the above factors, concerns have also been raised about
the allegiance of IRBs. Faced with growing fears of litigation and liability, several commentators have noted
that IRBs appear to have adopted a narrow ‘regulatory
model’, focusing on meeting the letter of the law (e.g.,
ensuring that all eight elements are spelled out in an
approved consent form), which appears to be aimed primarily at providing legal protection for the institution
(London, 2002; Dawson and Kass, 2005). Capturing these
concerns, in ruling on a lawsuit pressed by two families
against Johns Hopkins’ Kennedy Krieger Institute in their
controversial Lead Paint Abatement Trial, the Maryland
Court of Appeals issued a blistering critique that referred
to the Hopkins IRB as ‘in-house agents’ who were not ‘as
sufficiently concerned with ethicality of the research as
they were with the success of the experiment’ (Maryland
Court of Appeals, 2000).
In succinct summary, the Office of the Inspector General of the US HHS issued a report on IRBs that concluded: ‘IRBs are reviewing too much, too quickly, with
too little expertise; conducting minimal continuing review of approved research; facing conflicts of interest that
threaten their independence; and providing little training for clinical investigators and board members’ (Brown,
1998).

An Emerging Public Health Ethics
Perspective
445
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In recent years, there has been growing attention to ethics
from a public health perspective (Kass, 2001; Childress
et al., 2002; Buchanan and Miller, 2006b; Buchanan and
Miller, 2006c). Where medicine focuses on individual
health, public health is concerned with the health of the
entire population. Thus, in contrast to a fiduciary duty
to the individual patient, public health ethics is founded
on societal responsibility to protect and promote the
health of the population as a whole. The moral obligation to protect population health holds important implications for identifying appropriate ethical norms to guide
research ethics, including that conducted in international
settings.
The emerging public health ethics framework builds
on a line of reasoning that has focused on the role of
justice in evaluating the conduct of health research; in so
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doing, it gives greater weight to concerns for the collective good relative to the current emphasis on individual
rights (McCarthy, 1998; Kass, 2004). As mentioned, observers have noted a ‘paradigm shift’ in the evolution of
public concerns about health research in USA, moving
from a preoccupation with protecting participants from
harm to an interest in improving access to clinical trials
(Powers, 1998). In the historical context of public outrage
at the egregious misconduct of researchers at Tuskegee
and other research scandals, the Belmont Report concentrated accordingly on justice considerations internal
to the research process (National Commission, 1979).
Although concerns about distributing the benefits of research fairly in society are presented, the report focused
primarily on protecting research participants from harm
and exploitation. Over time, however, the weight of public moral concerns has shifted, from worries about the
risks of participating in research to greater recognition
of the potential benefits. For example, the research community once thought that women should be excluded
from health research due to a perceived greater vulnerability. Later, they recognized that it was unfair to conduct
research only on men, since the benefits of the research
for women would remain uncertain and justice demands
that the benefits be distributed fairly (Dresser, 1992; Kahn
et al., 1998; Weijer and Crouch, 1999). Thus, the inclusion of various population groups is now seen to be
obligatory. The demands of justice have expanded the
range of parties that ought to be considered morally relevant beyond the participants alone in determining the
acceptability of the research under consideration.
From a public health perspective, the range of risks and
benefits that are considered ethically significant must be
extended to take into account the social impact of the
research (Buchanan and Miller, 2006b, 2006c). In ethical
reviews, research is ultimately justified on the basis of its
social value; research without any social or scientific value
cannot be justified because it would place participants at
risk for no reason, that is, without compensating social
benefit (Emanuel et al., 2000). To determine the social
value of research, a comprehensive analysis should then
consider not only the risks and benefits to the research
participants themselves, but also the benefits and risks to
the population as a whole. Adopting a public health perspective thus entails the moral obligation of researchers
to consider the interests of the community as a whole as
well as the individual research participants.
A public health perspective on research ethics is based
on due recognition of the inherently social purpose of
health research. The evolution of ethical standards regulating health research (which has been dominated historically by clinical medical research) can be traced directly
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to the Hippocratic Oath and the decree that physicians
have an unqualified duty of fidelity to each individual
patient (Miller and Brody, 2003; Miller and Rosenstein,
2003). Due to its historical development within the context of clinical medical trials, the currently prevailing research ethics framework has focused virtually exclusively
on protecting and benefiting individual participants, to
the neglect of weighing the consequences of the research
for the community as a whole. While this standard may
be appropriate in the context of providing medical care,
research results have implications for the whole of society. Unlike the clinical context of providing personalized doctor–patient care, in the context of conducting
research, the moral consequences of inadvertently inflicting harm—of conducting a trial that turns out to
increase risk of serious morbidities or death—extend beyond the individual to the community at large. The consequences of the conduct of the research include, for example, the perceived trustworthiness of health research,
the perceived value of health science, and the likelihood
of community-wide adoption of a new intervention (e.g.,
HIV vaccine), should one eventually become available. In
contrast to basing standards on ethical norms appropriate to providing individual medical care, a public-health
perspective provides the theoretical foundation for incorporating due consideration of community interests
in setting ethical standards for the conduct of health research.

The Ethical Justification for
Community Oversight
As developed here, an ethical standard that requires community oversight of health research is justified on three
principled grounds: respect for community autonomy
and their right to self-determination; due consideration
of the consequences of the research for the community as
a whole; and, a more complete understanding of human
autonomy. Respect for community autonomy entails the
fundamental right of community members to exercise a
meaningful role in determining the conduct of research
that affects their lives (Buchanan et al., 2007). Vaccines,
for example, are designed not only to protect individuals
but to protect the community as a whole, including unvaccinated individuals via herd immunity, but this can be
achieved only if a large proportion of the population gets
vaccinated. Requiring community review is warranted
on the basis that communities are distinguishable entities
with interests that are distinct from individual interests
and that must be protected accordingly (Weijer, 1999;
Brody et al., 2005).

The principle of respect for community autonomy
acknowledges that the community has a non-negligible
stake in the decision to conduct research on its membership. The community, for example, has a collective right
to participate in decisions regarding the use of limited
fiscal or social resources (e.g., health clinic personnel
and facilities). Since justice demands that resources be
allocated fairly, the community must have a say in determining whether scarce resources are being diverted from
more pressing priorities or result in other potentially
important opportunities being lost (Brody et al., 2005).
This right encompasses protection against exploitation,
where exploitation is defined as one party taking unfair
advantage of another. As Wertheimer (1996) explains,
for exploitation to occur, it is not necessary for one party
to harm another—only that the benefit to one side be
disproportionate compared to the benefit to the other.
Given the enormous power of the pharmaceutical and
academic health research enterprise, it is critically important to establish a body with sufficient standing to set fair
terms of participation and protect against the potential
for exploitation. For our purposes here, it is worth recalling that, etymologically, the word ‘autonomy’ originally
referred not to individuals but to relationships among
city-states and communal independence from imperial
domination (Hill, 2001).
In addition to problems of diverting scarce resources
and exploiting community assets, the community bears
other types of risks that cannot be reduced to the individual level. The success of many health interventions
depends on their adoption by the population. To the
extent that the conduct of the research reinforces negative attitudes (e.g., human beings as ‘guinea pigs’), it
undermines trust in Western health science, which will
impede the adoption of effective interventions. Likewise,
the community as a whole must understand the implications of participation in certain types of research; seroconversion due to participation in HIV/AIDS vaccine trials, for example, has high potential for family, workforce
and community disruption if there is not a widespread
understanding of its significance. The use of public resources also calls for public accountability, a standard
that transcends individual consent and is not now part
of REC review. If researchers claim that making referrals
to a research project will not take an inordinate amount
of staff time, a body is necessary to monitor whether it
is interfering with the timely care of patients waiting for
an appointment.
The community should also have the capacity to determine the fair terms of benefits in return for their participation. The so-called ‘ancillary duties’ of researchers
have received increasing attention in recent years, taking
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up questions about the extent of researcher obligations,
for instance, to share the results with the community, to
offer related health services (e.g., HIV testing and counseling), and to provide medical care for the participants
(Belsky and Richardson, 2004; Macklin, 2004). The key
point here is that the scope of fair, nonexploitative benefits can be decided and endorsed neither by individual
participants nor by research institution–based RECs but
only by the community itself.
Finally, the ethical justification for community oversight can be established on the basis of a more complete understanding of human autonomy, in particular, as it relates to conceptualizing human identity.
In liberal Western societies, starting in the writings of
Hobbes and Locke, conceptions of personhood have
evolved in the direction of a radically individualistic,
atomistic view of the human condition (Taylor, 1985).
In this line of thinking, society and social cooperation come to exist only for the instrumental pursuit
of individual interests, and social norms are perceived
to be fundamentally antagonistic towards the unfettered quest for maximizing personal pleasure. This set
of assumptions about human identity presses toward
the position that the only right that warrants recognition is the right of individuals to choose not to
participate.
In contrast, a number of other schools of thought, including communitarianism, feminism and non-Western
traditions of communalism, have underscored the incoherence of such assumptions, noting that an individual’s
sense of identity is inextricably bound up with social relationships and membership in groups (Weijer, 1999;
Lindegger and Richter, 2000; Moodley, 2002). This
broader view gains traction starting with the fact that any
expression of self-understanding can be articulated only
in terms provided by a situated linguistic community. It
is only through participation in the life of a community
that one gains access to and learns the linguistic practices
that make possible perceptions of self and the value of
certain activities and ways of life. The very language used
for claiming that one wants to do something for some
reason (e.g., choosing to participate in research or not)
presupposes membership in a community in which those
terms have meaning. But if one can perceive certain desires only within a given cultural context, then one must
have an obligation to preserve the larger social grouping
and ensure its continuing vitality, for otherwise the community that reproduces the concepts that enable one to
make sense of one’s decisions (e.g., by discerning value
in select activities) would be lost. As Taylor (1985) and
others have argued, we find here a duty to protect the
community in which membership provides the capacity
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to find satisfaction and fulfillment in proffered ways of
life.
On the other side of this same coin, individuals are
systematically identified by their classification into social categories; thus, individual agreements to participate
in research inevitably raise questions about stigmatizing identifiable social groups (Brody et al., 2005). For
example, the higher prevalence of HIV/AIDS found in
Africans, which provides the primary justification for
targeting Africans in AIDS prevention research, has been
widely assumed to be attributable to promiscuous sexual practices, rather than other possible explanations
(Epstein, 2007). In multiracial, multiethnic or otherwise
diverse societies, the targeting of one group over another carries many meanings, about which the community identified for inclusion should be entitled to decide
whether they find the implications of their participation
acceptable. Hence, in direct parallel to the justification
for respect for individual autonomy, the community has
a right to protect itself against potential injuries to its
self-understanding and self-respect (Taylor, 1992).
If one accepts that communities per se deserve protection and have a right to self-determination, then standards must be set to ensure community engagement in
monitoring the conduct of health research. Based on the
principle of community autonomy, we argue that the
community is the best judge of its own interests; this
position is analogous to the principle of individual autonomy, where respect is afforded the individual’s right
to determine his or her own best interests. Hence, a process must be put in place whereby the community can
meaningfully deliberate about the implications for its
own interests of participating in a research project. One
process for achieving such community oversight is establishing Community Advisory Boards (CABs) (Buchanan
et al., 2007). Under the conditions specified below, CABs
provide a sound mechanism for securing community
ratification indicating that the research goals are valuable and methods acceptable to the community, before
the research is allowed to proceed.
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Currently, many CABs are set up for the express purpose of gaining access to groups targeted for recruitment
purposes, and individual CAB members are identified
and selected by the researchers for their ‘gate keeping’
ability to open doors and provide entry to these populations (Cox et al., 1998; Strauss et al., 2001; Morin
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et al., 2003; Reddy et al., 2007). In contrast, once the
ethical imperative for community oversight is acknowledged, then two key issues must be addressed. First, the
body charged with responsibility for assuring community oversight must be vested with legitimate authority
duly recognized by the community affected by the research to make decisions on their behalf. The second issue
of critical concern here is specifying how community is
defined.
While space constraint requires precluding a full discussion, in general, the two most common sources of
legitimate civil authority are divine right and democratic procedures (Weber, 1915/1946; Friedman, 1990;
Raz, 1990; Weijer and Emanuel, 2000; Richardson, 2002).
To set up bodies with valid decision-making power, extant community norms and practices cannot be circumvented; unless decisions are made by a recognized
source of legitimate authority, they will not be considered binding on community members. Thus, it is essential that researchers work within the existing system
of power and authority at both the national and local
levels.
The second major issue is the question of defining a community. A starting point for this discussion is the well-known distinction between geographic
and sociological definitions of community (Clark, 1973;
Plant, 1974). Health research projects have geographic
locations1 ; the catchment area(s) for participant recruitment are defined in the research protocols. The research protocols will also specify the inclusion and exclusion criteria for participation, which provide the criteria
for defining community sociologically (e.g., ethnic, cultural, linguistic, religious, gender, age, sexual orientation,
racial, etc.).
Thus, we see two major sources of authority (leaders
with inherited power and democratically elected representatives) and three major constituencies (existing authorities, residents, and potential participants) that must
be acknowledged when vesting CABs with legitimate authority. Based on the preceding considerations, we make
three recommendations with respect to instituting community oversight of international health research.
The first is that national health ministries and national
legislatures enact policies that require community review
of health research. These national policies should specify
the type of authority that will be recognized in constituting CABs, the level of geographic specificity, and the
types of sociologically defined communities that merit
protection against potential exploitation, and thus, representation on CABs. The national assembly should also
establish an appeals process for groups not previously
recognized to petition for inclusion.

The second recommendation is that the make-up
of CABs should accord with existing social practices
for making communally binding decisions.2 In contexts
where customary inherited authority is recognized, researchers must respect their executive agency and gain
their approval and authorization to proceed. The ruling
authority should be empowered to designate an agent or
agents who will provide permission, approval and agreement on the terms and conditions of local participation.
National legislation should stipulate whether any further community review is required at the local level. In
other locales, there may be well-established practices of
democratic decision-making and representation. There,
we recommend that CAB members should be elected by
both geographic and sociological community members
(see below).
Many countries have coexisting systems of rule by
inherited power and democratic plebiscites. The South
African Constitution, for example, provides one model
for achieving an appropriate balance between political
rights to vote for representatives to legislative bodies and
recognition of the authority of traditional leaders on matters at the local level. In such contexts, we recommend
that both sources of communal authority be consulted.
The issue of whether the respective approval processes
remain separate, or be combined, leads into our final
recommendation.
Third, we recommend that one of the two following
models of representation on CABs be adopted at the local level. In Model A, the CAB is composed of equal
numbers of representatives of the traditional authorities,
democratically elected residents, and participant representatives. The CAB will deliberate as a whole to determine whether the research should be approved, not
approved, or how it should be modified to make it acceptable to each of the three respective constituencies. In
Model B, there are two separate CABs, one composed of
traditional authorities, and the other of equal numbers
of geographically representative residents and targeted
participants. Since many sociological communities may
not be formally organized, we recommend soliciting volunteers. If more people volunteer than there are seats on
the board, we recommend a process of random selection
to ensure fairness.
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in developing countries, but largely so in developed nations as well. A growing appreciation of the impact of
health research on the community as a whole is precipitating a reassessment of the relative weight and understanding of the different ethical principles involved
in protecting populations from exploitation. We have
demonstrated here how new claims on justice oblige that
the rights, harms and benefits to the community as a
whole be taken into account in deliberations about the
ethical propriety of research in international settings, but
the analysis holds equally important implications for research in USA and other industrialized nations. To regain
reflective equilibrium, an ethical framework based on a
public health perspective yields a more satisfactory balance between the goals of gaining new knowledge and
providing adequate protections in conducting health research for countries across the entire development spectrum.
An ethical standard requiring the establishment of
CABs raises a host of issues, some of which cannot be
decided a priori but will have to evolve pragmatically
through experience and practice. One crucial issue that
needs to be addressed immediately is the operational independence of CABs. Currently, CABs are largely set up
and run by the individual research projects, which are
responsible for providing trainings or other resources
for their operations. This relationship of dependence is
untenable. In consultation with community representatives, national governments and international sponsors
need to begin discussions about sufficient set-asides to
ensure the CABs’ functional independence. The level of
resources necessary to make CABs operationally effective
and the responsibility for its provision are issues that will
likely vary from setting to setting, but must be addressed
as policies instituting their establishment are enacted.
The full scope of powers of CABs may also evolve in
practice, probably in relation to the setting and type of research proposed (e.g., experimental versus epidemiological). At a minimum, CABs should have the same scope
of powers of Research Ethics Committees in conducting
prior review of research protocols, and stipulating provisions to meet recognized ethical standards. But over time,
we envision that CABs play an appropriately more active role in securing greater community involvement, in
making the monitoring of the research in progress more
consistent, and in demanding greater accountability after
the research has formally been completed. For example,
there are already evolving practices of CABs calling for
more in-depth assessments of community perceptions of
the acceptability of the goals and methods of research,
through processes such as community forums, key informant interviews, focus groups, community surveys,
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and so on. The reliance on such practices is now seen
as part and parcel of community empowerment, respect
for human rights, support for self-determination and
the promotion of civic responsibility for the justice of
extant living conditions in the population. It is important that these practices be periodically reviewed and the
best practices codified into policy statements.
In contrast, one can readily imagine proposals to empower CABs to waive the right to individual informed
consent (or assent), by appealing, for example, to new
forms of proxy decision-making. Given the long track
record of historical abuses, we cannot find support for
this position at this time. In conclusion, the preceding
analysis has shown how community oversight is ethically imperative to protect against exploitation, to minimize potential misunderstandings about the intent of
the research, and to ensure fair terms of cooperation and
standards of care.
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Notes
1. The growing use of internet-based research belies
this statement to some extent, suggesting a seemingly
boundary-less domain. However, since the issue of
concern here is specifying an identifiable community,
questions raised by the use of the internet may be
moot, as any meaningful sampling process capable
of being generalized will require the same specification of geographic and sociological parameters (e.g.,
physicians practicing in the US).
2. The issue of conducting research in nations with
despotic regimes and a history of human rights abuses
is complicated. To the extent that CABs are permitted
because they are perceived as politically neutral and
non-threatening, they may foster the growth and vitality of civil society, which may prove to be beneficial
for the country in time. Thus, we would not dismiss
the possibility out of hand.
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